Phosphorylated fusion proteins
US6747131B1 · kind B1 · utility
Assignee
Inventor
Key dates
| Filing date | Nov 28, 2000 |
| Grant date | Jun 8, 2004 |
| Priority date | — |
| Expiry date | Sep 23, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Modified proteins, modified interferons &agr;'s and &bgr;'s, phosphorylated modified proteins and DNA sequences encoding the above, applications and uses thereof. Modified phosphorylated Hu-IFN-&agr;-like proteins are provided which carry an identifiable label such as a radio-label. Corresponding phosphorylatable Hu-IFN-&agr;-like proteins which contain a putative phosphorylation site. DNA sequences which encode a Hu-IFN-&agr;-like protein and contain a sequence encoding a putative phosphorylatable site. Appropriate expression vectors are used to transform compatible host cells of various microorganisms, such as E. coli. Numerous uses for the phosphorylated proteins are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.